Home/ Supplements/ Zinc/ Berbemycin

Berbemycin

product on market Capsule XYMOGEN Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 50% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Zinc is supported by strong evidence for immune function and metabolic support. Oregon grape, bayberry, and grapefruit extracts have limited research regarding their specific efficacy in combined formulations. Overall, the evidence coverage for this specific ingredient profile is minimal.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Berbemycin
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
120
Servings
Botanical with Nutrients
Product Type
50%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

5 mg (33% DV)
Within RDA (0.5× RDA) 263 studies (A:6, B:134)
Market median: 500.0mg (234 products) 95 studies (A:0, B:35)
Bayberry 4:1 Extract
200 mg
Grapefruti 4:1 Extract
50 mg

Other Ingredients

HPMC Stearic Acid Magnesium Stearate Silica
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

DIRECTIONS: Take one capsule daily, or as directed by your healthcare practitioner.

Warnings & Precautions

Avoid if pregnant, lactating, or allergic to any ingredient.

• Pharmaceutical Grade • Professional Use Only

CAUTIONS: Consult your healthcare practitioner before use, especially if taking medication.

Keep out of reach of children.

Formulation Notes

DOES NOT CONTAIN: Wheat, gluten, corn protein, yeast, soy, animal or dairy products, artificial colors, sweeteners, or preservatives.

Additional Information

TC# E1521201 REV. 071811

This package is completely recyclable (recycle)

VEGETABLE CAPSULES

STORAGE: Keep tightly closed in a cool, dry place.

Microbial Balance/Immune Support*

Metadata

Product Details

DSLD Entry Date2012-02-23
Product TypeBotanical with Nutrients
FormCapsule
BrandXYMOGEN
DSLD ID5946
Data Updated2026-04-11
Research

Research Evidence

397
Research Sources
55
Avg Quality
200
Meta Analysis
68
Rct
58
Systematic Review
53
Clinical Trial
9
Cochrane Review
2
Narrative Review
2
Regulatory Source
1
Observational
1
Other
1
Openfda Safety
A Zinc supplementation for improving pregnancy and infant outcome
Meta Analysis The Cochrane database of systematic reviews 2021 PubMed DOI
A Zinc supplementation for preventing mortality, morbidity, and growth failure in children aged 6 months to 12 years
Narrative Review The Cochrane database of systematic reviews 2023 PubMed DOI
A Oral zinc for treating diarrhoea in children
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Zinc supplements for preventing otitis media
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Zinc for the prevention or treatment of acute viral respiratory tract infections in adults: a rapid systematic review and meta-analysis of randomised controlled trials
Meta Analysis BMJ open 2021 PubMed DOI
A Zinc supplements for preventing otitis media
Meta Analysis The Cochrane database of systematic reviews 2010 PubMed DOI
A Zinc supplements for preventing otitis media
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Compression bandages or stockings versus no compression for treating venous leg ulcers
Meta Analysis The Cochrane database of systematic reviews 2021 PubMed DOI
A Zinc supplementation for mental and motor development in children
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Zinc for the common cold
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
View all evidence for Zinc →
Compare

Similar Products

View all Zinc products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.